Publication dates

All regions

Lymphoma Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, flow cytometry, hematology, more »


 
1-20 of about 8 900 reports for Lymphoma

Lymphoma Drug Pipeline Update 2014

Lymphoma Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... In 606 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 108 drugs. lymphoma drug pipeline update ...

Lymphoma Drug Pathway Analyzer 2014

Lymphoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the lymphoma ...

Follicular Lymphoma - Pipeline Review, H2 2014

Follicular Lymphoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of follicular lymphoma- the report reviews key pipeline products under drug profile section which includes, product description, moa and r ...

 Cutaneous T-Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Cutaneous T-Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of cutaneous t-cell lymphoma key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

 Follicular Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Follicular Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... And exclusivity details of follicular lymphoma key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under ...

 Mantle Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Mantle Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of mantle cell lymphoma key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

 Peripheral T-Cell Lymphomas (PTCL) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Peripheral T-Cell Lymphomas (PTCL) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to peripheral t-cell lymphomas (ptcl). - Api intelligence over marketed drugs ...

 Acute Lymphoblastic Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Acute Lymphoblastic Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of acute lymphoblastic lymphoma key products to exploit opportunities for generic drug development opportunities. - Identify ...

 T-Cell Lymphomas Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

T-Cell Lymphomas Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Cell lymphomas key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development for t ...

 Burkitt Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Burkitt Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of burkitt lymphoma key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

About 1 800 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe

  • Diagnostic Utility of a Clonality Test for Lymphoproliferative D...
  • January 2013
    8 pages
  • Cancer  

    T-cell Lymphoma  

  • Europe  

    Taiwan  

    United States  

View report >

Canada - Country Risk

September 2012

16 Companies for Lymphoma

Read our Company Profiles

Celgene Corp.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Seattle Genetics Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.